Cancer Clinical Investigation

Search results

• Bladder Cancer Advocacy Network Announces $600,000 in Funding to Accelerate Bladder Cancer Research

  John Sfakianos

  11/07/22

  1 item of Media coverage

  Press/Media

• Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR - Nature Biotechnology

  Manishkumar Patel, Kai Nie, Robert Sebra, Florian Krammer,, Sacha Gnjatic, Ivan Marazzi,, Ernesto Guccione, Arvin Dar, Megan Schwarz, Miriam Merad, Jocelyn Harris, Denis Torre, Seunghee Kim-Schulze & Jordi Ochando

  6/07/22

  1 item of Media coverage

  Press/Media

• Three Genes That Indicate a Potential Response to Selinexor Myeloma Therapy

  Samir Parekh & Alessandro Laganà

  6/07/22

  1 item of Media coverage

  Press/Media

• Positive Attitude, Paired With the Right Treatment Plan Can Have a ‘Medicinal Effect’ for MPNs

  John Mascarenhas

  5/07/22

  1 item of Media coverage

  Press/Media

• Science Surrounding MPNs ‘Continues to Evolve at a Rapid Pace’

  John Mascarenhas

  1/07/22

  1 item of Media coverage

  Press/Media

• More Novel Therapies Are on the Horizon in Multiple Myeloma

  Ajai Chari, Hearn Cho & Sundar Jagannath

  1/07/22

  1 item of Media coverage

  Press/Media

• An Introduction to the 2021 MPN Heroes®

  John Mascarenhas

  29/06/22

  1 item of Media coverage

  Press/Media

• Dr. Galsky on latest CheckMate-274 data for adjuvant nivolumab in bladder cancer

  Matthew Galsky

  27/06/22

  1 item of Media coverage

  Press/Media

• Four New York City Cancer Centers Receive $1 Million SU2C Grant to Improve Lung Cancer Care in Underserved Minority Patients

  Rajwanth Veluswamy

  27/06/22

  5 items of Media coverage

  Press/Media

• UTSW researchers develop blood test to predict liver cancer risk

  Yujin Hoshida & Bachir Taouli

  22/06/22 → 23/06/22

  9 items of Media coverage

  Press/Media

• Mount Sinai Researcher Receives Prestigious Award From the American Association of Indian Scientists in Cancer Research

  Nina Bhardwaj

  23/06/22

  1 item of Media coverage

  Press/Media

• Mount Sinai Researcher Receives Prestigious Award From the American Association of Indian Scientists in Cancer Research

  Nina Bhardwaj

  21/06/22

  1 item of Media coverage

  Press/Media

• Mount Sinai Researcher Receives Prestigious Award From the American Association of Indian Scientists in Cancer Research

  Nina Bhardwaj

  21/06/22

  12 items of Media coverage

  Press/Media

• Mount Sinai Researchers Discover Genes That Predict Good Response to Blood Cancer Therapy

  Samir Parekh & Alessandro Laganà

  16/06/22 → 17/06/22

  2 items of Media coverage

  Press/Media

• Researchers Discover Genes That Predict Good Response to Blood Cancer Therapy

  Samir Parekh & Alessandro Laganà

  16/06/22

  1 item of Media coverage

  Press/Media

• Researchers discover genes that predict good response to blood cancer therapy

  Samir Parekh & Alessandro Laganà

  15/06/22 → 16/06/22

  3 items of Media coverage

  Press/Media

• Mount Sinai researchers discover genes that predict good response to blood cancer therapy

  Samir Parekh & Alessandro Laganà

  16/06/22

  1 item of Media coverage

  Press/Media

• Mount Sinai researchers discover genes that predict good response to blood cancer therapy

  Samir Parekh & Alessandro Laganà

  15/06/22

  3 items of Media coverage

  Press/Media

• Researchers discover genes that predict good response to blood cancer therapy

  Samir Parekh & Alessandro Laganà

  15/06/22

  1 item of Media coverage

  Press/Media

• Dr. Mascarenhas on Updates from the MANIFEST Trial in Myelofibrosis

  John Mascarenhas

  11/06/22

  1 item of Media coverage

  Press/Media

• Morphosys Presents Multiple Analyses Of The MANIFEST Phase 2 Trial Investigating The Potential Of Pelabresib In The Treatment Of Myelofibrosis At EHA 2022

  John Mascarenhas

  10/06/22

  1 item of Media coverage

  Press/Media

• MorphoSys Presents Multiple Analyses Of The MANIFEST Phase 2 Trial Investigating The Potential Of Pelabresib In The Treatment Of Myelofibrosis At EHA 2022

  John Mascarenhas

  10/06/22

  32 items of Media coverage

  Press/Media

• Morphosys Presents Multiple Analyses Of The MANIFEST Phase 2 Trial Investigating The Potential Of Pelabresib In The Treatment Of Myelofibrosis At EHA 2022

  John Mascarenhas

  10/06/22

  1 item of Media coverage

  Press/Media

• Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment Oof Myelofibrosis at EHA 2022

  John Mascarenhas

  10/06/22

  1 item of Media coverage

  Press/Media

• MorphoSys Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment of Myelofibrosis at EHA 2022

  John Mascarenhas

  10/06/22

  2 items of Media coverage

  Press/Media